147 related articles for article (PubMed ID: 24480322)
1. Chronic inflammation and infection associate with a lower exercise training response in cystic fibrosis adolescents.
van de Weert-van Leeuwen PB; Hulzebos HJ; Werkman MS; Michel S; Vijftigschild LA; van Meegen MA; van der Ent CK; Beekman JM; Arets HG
Respir Med; 2014 Mar; 108(3):445-52. PubMed ID: 24480322
[TBL] [Abstract][Full Text] [Related]
2. Chronic infection and inflammation affect exercise capacity in cystic fibrosis.
van de Weert-van Leeuwen PB; Slieker MG; Hulzebos HJ; Kruitwagen CL; van der Ent CK; Arets HG
Eur Respir J; 2012 Apr; 39(4):893-8. PubMed ID: 21885387
[TBL] [Abstract][Full Text] [Related]
3. Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.
Dassios TG; Katelari A; Doudounakis S; Dimitriou G
Respir Care; 2014 Mar; 59(3):363-70. PubMed ID: 23983273
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of a program of hospital-supervised physical training in patients with cystic fibrosis.
Turchetta A; Salerno T; Lucidi V; Libera F; Cutrera R; Bush A
Pediatr Pulmonol; 2004 Aug; 38(2):115-8. PubMed ID: 15211693
[TBL] [Abstract][Full Text] [Related]
5. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis.
Jensen P; Johansen HK; Lanng S; Høiby N
Pediatr Res; 2001 Mar; 49(3):423-8. PubMed ID: 11228271
[TBL] [Abstract][Full Text] [Related]
6. Exercise oxidative skeletal muscle metabolism in adolescents with cystic fibrosis.
Werkman M; Jeneson J; Helders P; Arets B; van der Ent K; Velthuis B; Nievelstein R; Takken T; Hulzebos E
Exp Physiol; 2016 Mar; 101(3):421-31. PubMed ID: 26707538
[TBL] [Abstract][Full Text] [Related]
7. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.
Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E
Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907
[TBL] [Abstract][Full Text] [Related]
8. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
9. [Association between chronic colonization or infection with Pseudomonas aeruginosa and bronchial hyperreactivity in patients with cystic fibrosis].
Valverde-Molina J; Sánchez-Solís M; Pastor-Vivero MD; García-Marcos L
Arch Bronconeumol; 2008 Apr; 44(4):180-4. PubMed ID: 18423178
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection.
Hector A; Schäfer H; Pöschel S; Fischer A; Fritzsching B; Ralhan A; Carevic M; Öz H; Zundel S; Hogardt M; Bakele M; Rieber N; Riethmueller J; Graepler-Mainka U; Stahl M; Bender A; Frick JS; Mall M; Hartl D
Am J Respir Crit Care Med; 2015 Apr; 191(8):914-23. PubMed ID: 25632992
[TBL] [Abstract][Full Text] [Related]
11. Influence of inflammatory response, infection, and pulmonary function in cystic fibrosis.
Pereira LC; Moreira EA; Bennemann GD; Moreno YM; Buss Zda S; Barbosa E; Ludwig-Neto N; Wilhelm Filho D; Fröde TS
Life Sci; 2014 Jul; 109(1):30-6. PubMed ID: 24931908
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in serum and sputum from patients with cystic fibrosis.
Schiøtz PO; Egeskjold EM; Høiby N; Permin H
Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive assessment of exercise performance in children with cystic fibrosis (CF) and non-cystic fibrosis bronchiectasis: is there a CF specific muscle defect?
Rosenthal M; Narang I; Edwards L; Bush A
Pediatr Pulmonol; 2009 Mar; 44(3):222-30. PubMed ID: 19206180
[TBL] [Abstract][Full Text] [Related]
14. Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection.
Giordano A; Magni A; Filadoro F; Graziani C; Quattrucci S; Cipriani P
New Microbiol; 1998 Oct; 21(4):375-8. PubMed ID: 9812319
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
16. Does
Kampouras A; Hatziagorou E; Avramidou V; Georgopoulou V; Kirvassilis F; Tsanakas J
Pulm Med; 2019; 2019():3786245. PubMed ID: 31934449
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
Holby N; Olling S
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
[TBL] [Abstract][Full Text] [Related]
18. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
[TBL] [Abstract][Full Text] [Related]
19. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS
APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
